Literature DB >> 19757044

A functional SNP of the Interleukin-18 gene is associated with the presence of hepatocellular carcinoma in hepatitis B virus-infected patients.

Yong Seok Kim1, Jae Youn Cheong, Sung Won Cho, Kee Myung Lee, Jae Chul Hwang, Bermseok Oh, Kuchan Kimm, Jung A Lee, Byung Lae Park, Hyun Sub Cheong, Hyoung Doo Shin, Jin Hong Kim.   

Abstract

BACKGROUND/AIM: The natural course of hepatitis B virus (HBV) infection is likely related to host immune factors. Interleukin-18 (IL-18) plays a significant role in immune defense. This study was undertaken to determine the association between the presence of hepatocellular carcinoma (HCC) and single-nucleotide polymorphisms (SNPs) in the IL-18 gene in HBV-infected patients.
METHODS: Between March 2002 and December 2004, 730 Korean subjects were enrolled in two different groups: (1) chronic carrier without HCC (n=637) and (2) HCC (n=93). We analyzed SNPs at four polymorphic sites in the IL-18 gene at positions -667G>T, -148G>C, +8925C>G, and +13925A>C in the study subjects. To evaluate the functional significance of SNPs in the IL-18 gene promoter region, we performed a reporter gene assay in HepG2 and Hep3B cells transfected with different alleles.
RESULTS: The IL-18 -148C allele, +8925G allele, +13925C allele, and haplotype 3 (TCGC) were associated with the presence of HCC in codominant and dominant models. Furthermore, functional analyses using the reporter gene assay revealed that the -148C allele conferred significantly lower promoter activity.
CONCLUSIONS: This study indicates that the -148C, +8925G, and +13925C alleles of the IL-18 gene are associated with the presence of HCC and the 148G>C SNP is functionally important in determining disease outcome. © Springer Science+Business Media, LLC 2009

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19757044     DOI: 10.1007/s10620-009-0970-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

1.  An essential role for NF-kappa B in IL-18-induced IFN-gamma expression in KG-1 cells.

Authors:  H Kojima; Y Aizawa; Y Yanai; K Nagaoka; M Takeuchi; T Ohta; H Ikegami; M Ikeda; M Kurimoto
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates.

Authors:  D Cho; H Song; Y M Kim; D Houh; D Y Hur; H Park; D Yoon; K H Pyun; W J Lee; M Kurimoto; Y B Kim; Y S Kim; I Choi
Journal:  Cancer Res       Date:  2000-05-15       Impact factor: 12.701

3.  Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation.

Authors:  V Giedraitis; B He; W X Huang; J Hillert
Journal:  J Neuroimmunol       Date:  2001-01-01       Impact factor: 3.478

4.  Potent antitumor effects mediated by local expression of the mature form of the interferon-gamma inducing factor, interleukin-18 (IL-18).

Authors:  T Osaki; W Hashimoto; A Gambotto; H Okamura; P D Robbins; M Kurimoto; M T Lotze; H Tahara
Journal:  Gene Ther       Date:  1999-05       Impact factor: 5.250

5.  Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.

Authors:  M J Micallef; T Tanimoto; K Kohno; M Ikeda; M Kurimoto
Journal:  Cancer Res       Date:  1997-10-15       Impact factor: 12.701

6.  Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.

Authors:  Jae Youn Cheong; Sung Won Cho; Il Lan Hwang; Seung Kew Yoon; June Hyuk Lee; Choon Sik Park; Jong Eun Lee; Ki Baik Hahm; Jin Hong Kim
Journal:  J Gastroenterol Hepatol       Date:  2006-07       Impact factor: 4.029

7.  Lack of association between hepatitis B virus infection and polymorphism of mannose-binding lectin gene in Korean population.

Authors:  Jae Youn Cheong; Sung Won Cho; Sun Kyo Lim; Do Hyun Shin; Seung Kew Yoon; Jong Eun Lee; Ki Baik Hahm; Jin Hong Kim
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

8.  Cytokine inhibition of the hepatitis B virus core promoter.

Authors:  R Romero; J E Lavine
Journal:  Hepatology       Date:  1996-01       Impact factor: 17.425

9.  Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.

Authors:  K Ando; T Moriyama; L G Guidotti; S Wirth; R D Schreiber; H J Schlicht; S N Huang; F V Chisari
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

10.  Direct activation of human CD8+ cytotoxic T lymphocytes by interleukin-18.

Authors:  M Kohyama; K Saijyo; M Hayasida; T Yasugi; M Kurimoto; T Ohno
Journal:  Jpn J Cancer Res       Date:  1998-10
View more
  17 in total

1.  Association of interleukin-8 gene polymorphisms with the risk of hepatocellular carcinoma.

Authors:  Jun-li Wang; Le-gen Nong; Ye-sheng Wei; Yu-jin Tang; Jian-chu Wang; Chun-fang Wang
Journal:  Mol Biol Rep       Date:  2014-01-01       Impact factor: 2.316

2.  Relationship between interleukin 18 polymorphisms and susceptibility to chronic hepatitis B virus infection.

Authors:  Na Li; Yu-Feng Gao; Tian-Chen Zhang; Ping Chen; Xu Li; Fei Su
Journal:  World J Hepatol       Date:  2012-03-27

Review 3.  Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.

Authors:  Yi-Fang Han; Jun Zhao; Li-Ye Ma; Jian-Hua Yin; Wen-Jun Chang; Hong-Wei Zhang; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2011-10-14       Impact factor: 5.742

Review 4.  Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms.

Authors:  Mahmoud Fathy Dondeti; Eman Anwar El-Maadawy; Roba Mohamed Talaat
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

5.  Association of polymorphisms in interleukin-18 and interleukin-28B genes with outcomes of hepatitis B virus infections: a meta-analysis.

Authors:  Pu Xia; Mo Zhou; Dao Song Dong; Ya-Nan Xing; Yang Bai
Journal:  Tumour Biol       Date:  2013-09-12

6.  Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients.

Authors:  Liang-Tsai Hsiao; Hao-Yuan Wang; Ching-Fen Yang; Tzeon-Jye Chiou; Jyh-Pyng Gau; Yuan-Bin Yu; Hsiao-Ling Liu; Wen-Chun Chang; Po-Min Chen; Cheng-Hwai Tzeng; Yu-Jiun Chan; Muh-Hwa Yang; Jin-Hwang Liu; Yi-Hsiang Huang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

7.  Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma.

Authors:  Xian-Peng Li; Xiao-Yu Yang; Ewelina Biskup; Jiang Zhou; Hong-Liang Li; Yi-Feng Wu; Ming-Liang Chen; Feng Xu
Journal:  Oncotarget       Date:  2015-09-08

8.  Association between IL-18 polymorphisms, serum levels, and HBV-related hepatocellular carcinoma in a Chinese population: a retrospective case-control study.

Authors:  Jingui Bao; Yu Lu; Yan Deng; Chengzhi Rong; Yanqiong Liu; Xiuli Huang; Liuying Song; Shan Li; Xue Qin
Journal:  Cancer Cell Int       Date:  2015-07-25       Impact factor: 5.722

9.  IL18 Gene Variants Influence the Susceptibility to Chagas Disease.

Authors:  Daniel A Leon Rodriguez; F David Carmona; Luis Eduardo Echeverría; Clara Isabel González; Javier Martin
Journal:  PLoS Negl Trop Dis       Date:  2016-03-30

10.  Association between Interleukin-18 Polymorphisms and Hepatocellular Carcinoma Occurrence and Clinical Progression.

Authors:  Hon-Kit Lau; Ming-Ju Hsieh; Shun-Fa Yang; Hsiang-Ling Wang; Wu-Hsien Kuo; Hsiang-Lin Lee; Chao-Bin Yeh
Journal:  Int J Med Sci       Date:  2016-07-05       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.